A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer (Q33751771)
Jump to navigation
Jump to search
scientific article published on November 19, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer |
scientific article published on November 19, 2010 |
Statements
1 reference
A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer (English)
1 reference
A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer (English)
1 reference
Sophia Agelaki
Athina Agelidou
1 reference
Ioannis Varthalitis
1 reference
Kostas Syrigos
1 reference
Nikolaos Kentepozidis
1 reference
Georgia Pavlakou
1 reference
Athanasios Kotsakis
1 reference
Emmanouel Kontopodis
1 reference
Vassilis Georgoulias
1 reference
Athanasios G. Pallis
19 November 2010
1 reference
1 reference
1 reference
1 reference
1 reference
10
1 reference
633
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference